Tobacco Smoke Control

Tobacco Smoke Control- Tobacco smoke control refers to the implementation of measures to reduce exposure to tobacco smoke, both from firsthand and secondhand sources.

Types of Tobacco Smoke:

Firsthand smoke: Inhaled directly by the smoker.
Secondhand smoke: Also known as environmental tobacco smoke (ETS), it’s a mixture of smoke exhaled by smokers and the smoke released from the burning end of a cigarette, cigar, or pipe. It contains over 7,000 chemicals, including many toxic and carcinogenic substances.

Health Risks of Secondhand Smoke:

Cardiovascular diseases: Heart attacks, stroke
Respiratory problems: Lung cancer, chronic obstructive pulmonary disease (COPD), asthma, respiratory infections
Cancer: Lung cancer, breast cancer, bladder cancer
Other health issues: Sudden infant death syndrome (SIDS), ear infections, developmental problems in children

Tobacco Smoke Control Measures:

Smoke-free laws: Prohibit smoking in public places, workplaces, and indoor areas.
Designated smoking areas: If allowed, these areas must be well-ventilated and separated from non-smoking areas.
Public awareness campaigns: Educate the public about the dangers of secondhand smoke.
Restrictions on tobacco advertising and promotion: Reduce the appeal of tobacco products.
Smoking cessation programs: Help smokers quit.
Increased taxes on tobacco products: Make tobacco less affordable.

Benefits of Tobacco Smoke Control:

Reduces exposure to harmful chemicals
Improves air quality
Protects non-smokers from health risks
Creates healthier environments

Examples of Successful Tobacco Smoke Control Policies:

Smoke-free workplaces: Numerous countries and regions have implemented comprehensive smoke-free workplace laws.
Smoke-free public places: Many countries have banned smoking in restaurants, bars, and other public places.
Smoke-free vehicles: Some jurisdictions prohibit smoking in vehicles with children present.

International Initiatives:

World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC): An international treaty that aims to reduce tobacco use and its harmful effects.

Conclusion:

Tobacco smoke control is a critical public health issue. By implementing effective measures, we can significantly reduce exposure to secondhand smoke and protect the health of non-smokers.

What is Required Tobacco Smoke Control

Required tobacco smoke control measures vary depending on the specific jurisdiction and the type of environment. However, some common requirements include:

Smoke-free workplaces: Most workplaces, including offices, factories, and healthcare facilities, are required to be completely smoke-free. This often includes outdoor areas as well.
Smoke-free public places: Many jurisdictions prohibit smoking in public places such as restaurants, bars, cafes, and public transportation.
Designated smoking areas: If allowed, designated smoking areas must be clearly separated from non-smoking areas and adequately ventilated.
Restrictions on smoking in vehicles: Some jurisdictions prohibit smoking in vehicles with children present.
Clear signage: Prominent “No Smoking” signs must be displayed in all smoke-free areas.

Important Note: These are general examples, and specific requirements can vary significantly. It’s crucial to consult the relevant local laws and regulations for detailed information.

Key Considerations:

Protecting non-smokers: The primary goal of tobacco smoke control is to protect non-smokers from the harmful effects of secondhand smoke.
Creating healthy environments: Smoke-free policies contribute to healthier environments for both employees and the general public.
Enforcing regulations: Effective enforcement of smoke-free laws is essential to ensure compliance and achieve the desired public health benefits.

Who is Required Tobacco Smoke Control

Courtesy: Ministry of Health & Family Welfare

The entities required to comply with tobacco smoke control measures vary depending on the specific laws and regulations in place. However, some of the key entities that are typically required to comply include:

Businesses: This includes a wide range of businesses, such as restaurants, bars, cafes, hotels, offices, factories, and retail stores.
Public institutions: This includes government offices, hospitals, schools, colleges, and other public buildings.
Transportation providers: This includes airlines, trains, buses, and other forms of public transportation.
Property owners: This includes landlords, property managers, and homeowners (in some cases).

Key Points:

Compliance is crucial: Failure to comply with tobacco smoke control laws can result in fines, penalties, and other legal consequences.
Responsibility: It’s important for businesses and other entities to understand their responsibilities under the law and to take steps to ensure compliance.
Employee training: Training employees about the smoke-free policies and their responsibilities in enforcing them is essential.

Disclaimer: This information is for general knowledge and guidance only and does not constitute legal advice. It’s crucial to consult with legal professionals or relevant authorities for specific guidance on tobacco smoke control requirements in your jurisdiction.

When is Required Tobacco Smoke Control

Required tobacco smoke control measures are generally in effect at all times within the designated smoke-free areas.

Workplaces: Smoke-free policies typically apply during all working hours and may extend to break areas, outdoor areas, and company vehicles.
Public places: Smoke-free regulations usually apply 24/7 within the specified areas, such as restaurants, bars, and public transportation.

Important Note:

Specific regulations and enforcement may vary.
It’s crucial to consult local laws and ordinances for the most accurate and up-to-date information on tobacco smoke control requirements in a particular jurisdiction.

Where is Required Tobacco Smoke Control

Required tobacco smoke control typically applies to a wide range of areas, including:

Workplaces:
- Offices
- Factories
- Hospitals
- Schools
- Colleges
- Other workplaces
Public places:
- Restaurants
- Bars
- Cafes
- Public transportation (buses, trains, airplanes)
- Public buildings (government offices, libraries, museums)
- Parks (in some cases)
- Playgrounds (in some cases)
Other areas:
- Vehicles with children present (in some jurisdictions)

Important Note: The specific locations where tobacco smoke control is required can vary significantly depending on the specific laws and regulations in place within a particular jurisdiction.

How is Required Tobacco Smoke Control

Courtesy: Dr Wealz

Required tobacco smoke control is enforced through a combination of methods, including:

Legislation:
- Clear and comprehensive laws and regulations that prohibit smoking in designated areas.
- These laws often include penalties for violations, such as fines.
Enforcement:
- Government agencies: Responsible for enforcing smoke-free laws, such as health departments or police departments.
- Inspections: Regular inspections of workplaces and public places to ensure compliance.
- Complaints: Individuals can file complaints about violations to the relevant authorities.
Public awareness campaigns:
- Educate the public about the dangers of secondhand smoke and the importance of smoke-free environments.
- Promote compliance with smoke-free laws.
Employee training:
- Train employees about smoke-free policies and their responsibilities in enforcing them.
Signage:
- Clear and prominent “No Smoking” signs are displayed in all smoke-free areas.

Case Study on Tobacco Smoke Control

Here’s a case study on tobacco smoke control, focusing on the success of smoke-free workplace policies:

Case Study: Smoke-free Workplaces in the United States

Background:

Prior to the 1990s, smoking in the workplace was common in many parts of the US.
Secondhand smoke exposure was widespread, leading to significant health risks for employees.

Intervention:

Starting in the 1990s, a movement emerged to implement smoke-free workplace policies.
This involved:
- Advocacy efforts by public health organizations and employee groups.
- Legislative action at the state and local levels.
- Public awareness campaigns to educate the public about the dangers of secondhand smoke.

Implementation:

Over time, numerous states and municipalities enacted comprehensive smoke-free workplace laws.
These laws typically prohibited smoking in all indoor areas of workplaces, including offices, factories, and other workspaces.
Some laws also extended to outdoor areas, such as patios and break rooms.

Outcomes:

Improved employee health:
- Significant reductions in employee exposure to secondhand smoke.
- Decreases in respiratory illnesses among employees.
- Improved cardiovascular health.
Increased productivity:
- Reduced absenteeism due to smoking-related illnesses.
- Improved employee morale and job satisfaction.
Cleaner work environments:
- Improved indoor air quality.
- Reduced cleaning costs associated with smoke residue.

Challenges:

Initial resistance: Some businesses and employees initially resisted smoke-free policies.
Enforcement: Ensuring consistent enforcement of smoke-free laws can be challenging.
Addressing the needs of smokers: Providing support for smokers who wish to quit is crucial for the long-term success of smoke-free policies.

Lessons Learned:

Strong legislation: Comprehensive and well-enforced smoke-free laws are essential for success.
Public support: Strong public support is crucial for the implementation and long-term success of smoke-free policies.
Comprehensive approach: A multi-faceted approach that includes legislation, education, and support for smokers is most effective.

Conclusion:

The implementation of smoke-free workplace policies in the United States has been a significant public health success story. These policies have not only protected employees from the harmful effects of secondhand smoke but have also created healthier and more productive work environments.

Note: This is a simplified case study. Real-world situations are often more complex and involve a variety of factors.

This case study demonstrates the positive impact of comprehensive tobacco smoke control measures. Similar successes can be replicated in other countries and regions through strong political will, effective public health interventions, and sustained efforts to create smoke-free environments.

White paper on Tobacco Smoke Control

A Critical Public Health Imperative

1. Introduction

Tobacco use remains a leading cause of preventable death and disease globally. While significant strides have been made in tobacco control, the pervasive presence of tobacco smoke continues to pose a serious threat to public health. This white paper aims to underscore the critical importance of comprehensive tobacco smoke control measures and outline key strategies for their effective implementation.

2. The Burden of Tobacco Smoke

Direct Harm: Tobacco smoking directly causes numerous diseases, including lung cancer, heart disease, stroke, chronic obstructive pulmonary disease (COPD), and various cancers.
Secondhand Smoke (SHS): Exposure to secondhand smoke, a complex mixture of gases and particles, poses significant health risks to non-smokers, including:
- Increased risk of heart disease, stroke, and lung cancer.
- Respiratory problems, especially in children (asthma, bronchitis, pneumonia).
- Increased risk of sudden infant death syndrome (SIDS).
- Eye, nose, and throat irritation.

3. The Need for Comprehensive Tobacco Smoke Control

Effective tobacco smoke control requires a multi-pronged approach encompassing:

Smoke-free Legislation:
- Workplace: Enforce smoke-free policies in all workplaces, including offices, factories, and healthcare facilities.
- Public Spaces: Prohibit smoking in public places such as restaurants, bars, cafes, public transportation, and parks.
- Outdoor Spaces: Consider restrictions on smoking in outdoor areas, especially those frequented by children.
Public Awareness Campaigns:
- Educate the public about the dangers of secondhand smoke.
- Promote the benefits of smoke-free environments.
- Disseminate information on cessation resources.
Enforcement:
- Establish clear and enforceable regulations.
- Implement effective monitoring and enforcement mechanisms.
- Address public complaints promptly and effectively.
Support for Smokers:
- Provide access to cessation programs and resources.
- Offer support services to help smokers quit.
Taxation:
- Increase taxes on tobacco products to reduce affordability and consumption.

4. Key Considerations

Protecting Vulnerable Populations: Prioritize the protection of vulnerable populations, such as children, pregnant women, and individuals with chronic health conditions.
Equity and Social Justice: Ensure that tobacco control policies are implemented equitably and do not disproportionately impact marginalized communities.
Economic Benefits: Highlight the economic benefits of smoke-free environments, such as reduced healthcare costs and increased productivity.
International Collaboration: Foster international cooperation and knowledge sharing to strengthen global tobacco control efforts.

5. Conclusion

Tobacco smoke control is a critical public health imperative. By implementing comprehensive and effective measures, we can significantly reduce exposure to secondhand smoke, protect public health, and create healthier environments for all. This white paper serves as a call to action to prioritize tobacco smoke control and work towards a smoke-free future.

Disclaimer: This white paper provides general information and should not be considered medical or legal advice.

Note: This white paper provides a basic framework. For a more comprehensive document, you would need to include specific data, statistics, and citations to support the arguments presented.

Industrial Application of Tobacco Smoke Control

Courtesy: World Health Organization (WHO)

While the term “industrial application of tobacco smoke control” might seem contradictory, there are a few ways this concept can be interpreted:

Industrial Hygiene and Safety: In industrial settings, controlling any type of smoke or airborne particulate matter is crucial for worker safety and health. This could involve:
- Ventilation systems: Powerful exhaust systems to remove smoke and fumes from welding, soldering, or other industrial processes.
- Personal protective equipment (PPE): Providing respirators and other safety gear to protect workers from exposure to harmful fumes.
- Regular air quality monitoring: To ensure that workplace air meets safety standards.
Research and Development: The tobacco industry itself conducts research and development to:
- Develop less harmful tobacco products: This includes research into reduced-risk products like e-cigarettes and heated tobacco products.
- Improve filtration technologies: To reduce the harmful components of tobacco smoke.
- Study the effects of tobacco smoke on human health: This research aims to better understand the mechanisms of tobacco-related diseases.

Important Note: It’s crucial to distinguish between these legitimate industrial applications of smoke control and the tobacco industry’s marketing and lobbying efforts, which often aim to downplay the harms of smoking and undermine effective public health policies.

References

^ Jump up to:^a ^b Gately, Iain (2004) [2003]. Tobacco: A Cultural History of How an Exotic Plant Seduced Civilization. Diane. pp. 3–7. ISBN 978-0-8021-3960-3. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
^ Jump up to:^a ^b ^c Lloyd, John; Mitchinson, John (25 July 2008). The Book of General Ignorance. Harmony Books. ISBN 978-0-307-39491-0.
^ West, Robert; Shiffman, Saul (2007). Fast Facts: Smoking Cessation. Health Press Ltd. p. 28. ISBN 978-1-903734-98-8.
^ Jump up to:^a ^b ^c Wigand, Jeffrey S. (July 2006). “ADDITIVES, CIGARETTE DESIGN and TOBACCO PRODUCT REGULATION” (PDF). Mt. Pleasant, MI 48804: Jeffrey Wigand. Archived (PDF) from the original on 16 May 2011. Retrieved 14 February 2009.
^ Jump up to:^a ^b Gilman & Xun 2004, p. 318
^ Jump up to:^a ^b Parrott, A. C.; Winder, G. (1989). “Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate”. Psychopharmacology. 97 (2): 257–261. doi:10.1007/BF00442260. PMID 2498936. S2CID 4842374.
^ Jump up to:^a ^b Parkin, C.; Fairweather, D. B.; Shamsi, Z.; Stanley, N.; Hindmarch, I. (1998). “The effects of cigarette smoking on overnight performance”. Psychopharmacology. 136 (2): 172–178. doi:10.1007/s002130050553. PMID 9551774. S2CID 22962937.
^ Gilman & Xun 2004, pp. 320–321
^ Benowitz, Neal L. (1 February 2009). “Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics”. Annual Review of Pharmacology and Toxicology. 49 (1): 57–71. doi:10.1146/annurev.pharmtox.48.113006.094742. ISSN 0362-1642. PMC 2946180. PMID 18834313.
^ Jump up to:^a ^b ^c Proctor 2000, p. 228
^ Jump up to:^a ^b Doll, R.; Hill, B. (June 2004). “The mortality of doctors in relation to their smoking habits: a preliminary report: (Reprinted from Br Med J 1954:ii;1451-5)”. BMJ (Clinical Research Ed.). 328 (7455): 1529–1533, discussion 1533. doi:10.1136/bmj.328.7455.1529. ISSN 0959-8138. PMC 437141. PMID 15217868.
^ Jump up to:^a ^b VJ Rock, MPH, A Malarcher, JW Kahende, K Asman, MSPH, C Husten, MD, R Caraballo (9 November 2007). “Cigarette Smoking Among Adults — United States, 2006”. United States Centers for Disease Control and Prevention. Archived from the original on 16 August 2019. Retrieved 1 January 2009. In 2006, an estimated 20.8% (45.3 million) of U.S. adults[…]
^ Jump up to:^a ^b ^c ^d “WHO/WPRO-Smoking Statistics”. World Health Organization Regional Office for the Western Pacific. 28 May 2002. Archived from the original on 8 November 2009. Retrieved 1 January 2009.
^ Giovino, GA; Mirza, SA; Samet, JM; Gupta, PC; Jarvis, MJ; Bhala, N; Peto, R; Zatonski, W; Hsia, J; Morton, J; Palipudi, KM; Asma, S; GATS Collaborative, Group (18 August 2012). “Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys”. Lancet. 380 (9842): 668–79. doi:10.1016/S0140-6736(12)61085-X. ISSN 0140-6736. PMID 22901888. S2CID 12450625.
^ Jump up to:^a ^b The World Health Organization, and the Institute for Global Tobacco Control, Johns Hopkins School of Public Health (2001). “Women and the Tobacco Epidemic: Challenges for the 21st Century” (PDF). World Health Organization. pp. 5–6. Archived from the original (PDF) on 28 November 2003. Retrieved 2 January 2009.
^ Jump up to:^a ^b “Surgeon General’s Report—Women and Smoking”. Centers for Disease Control and Prevention. 2001. p. 47. Archived from the original on 10 July 2009. Retrieved 3 January 2009.
^ Jump up to:^a ^b ^c ^d “Tobacco”. www.who.int. Retrieved 24 February 2024.
^ Jump up to:^a ^b ^c ^d ^e Chandrupatla, Siddardha G.; Tavares, Mary; Natto, Zuhair S. (27 July 2017). “Tobacco Use and Effects of Professional Advice on Smoking Cessation among Youth in India”. Asian Pacific Journal of Cancer Prevention. 18 (7): 1861–1867. doi:10.22034/APJCP.2017.18.7.1861. ISSN 2476-762X. PMC 5648391. PMID 28749122.
^ The Lancet (26 September 2009). “Tobacco smoking:why start?”. The Lancet. 374 (9695): 1038. doi:10.1016/s0140-6736(09)61680-9. PMID 19782852. S2CID 37513171.
^ Wilbert, Johannes (28 July 1993). Tobacco and Shamanism in South America. Yale University Press. ISBN 978-0-300-05790-4. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
^ Robicsek, Francis (January 1979). The Smoking Gods: Tobacco in Maya Art, History, and Religion. University of Oklahoma Press. p. 30. ISBN 978-0-8061-1511-5.
^ F.J.Carod-Artal (1 July 2011). “Hallucinogenic drugs in pre-Columbian Mesoamerican cultures”. Neurología. 30 (1): 42–49. doi:10.1016/j.nrleng.2011.07.010. PMID 21893367.
^ Nordenskiold, Erland (1929), “The American Indian as an Inventor”, Journal of the Royal Anthropological Institute, 59: 277, doi:10.2307/2843888, JSTOR 2843888
^ Heckewelder, John Gottlieb Ernestus; Reichel, William Cornelius (June 1971) [1876]. History, manners, and customs of the Indian nations who once inhabited Pennsylvania and the neighboring states (PDF). The Historical society of Pennsylvania. p. 149. ISBN 978-0-405-02853-3. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
^ Diéreville; Webster, John Clarence; Webster, Alice de Kessler Lusk (1933). “Relation of the voyage to Port Royal in Acadia or New France”. The Champlain Society. They smoke with excessive eagerness […] men, women, girls and boys, all find their keenest pleasure in this way {{cite journal}}: Cite journal requires |journal= (help)
^ Gottsegen, Jack Jacob (1940). “Tobacco: A Study of Its Consumption in the United States”. Pitman Publishing Company: 107. Archived from the original on 14 January 2023. Retrieved 22 March 2009> {{cite journal}}: Cite journal requires |journal= (help)
^ Balls, Edward K. (1 October 1962). Early Uses of California Plants. University of California Press. pp. 81–85. ISBN 978-0-520-00072-8. Retrieved 22 March 2009. Early Uses of California Plants.
^ Jordan, Ervin L. Jr. “Jamestown, Virginia, 1607–1907: An Overview”. University of Virginia. Archived from the original on 17 October 2002. Retrieved 22 February 2009. {{cite journal}}: Cite journal requires |journal= (help)
^ Kulikoff, Allan (1 August 1986). Tobacco and Slaves: The Development of Southern Cultures in the Chesapeake. The University of North Carolina Press. ISBN 978-0-8078-4224-9. Retrieved 22 March 2009. Tobacco & Slaves: The Development of Southern Cultures in the Chesapeake.
^ Gilman & Xun 2004, p. 38
^ Gilman & Xun 2004, pp. 92–99
^ Gilman & Xun 2004, pp. 15–16
^ King James I of England (16 April 2002) [1604]. “A Counterblaste to Tobacco”. University of Texas at Austin. Archived from the original on 18 May 2009. Retrieved 22 March 2009. {{cite journal}}: Cite journal requires |journal= (help)
^ Burns, Eric (28 September 2006). The Smoke of the Gods: A Social History of Tobacco. Temple University Press. pp. 134–135. ISBN 978-1-59213-480-9. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
^ Proctor 2000, p. 178
^ Proctor 2000, p. 219
^ Proctor 2000, p. 187
^ Jump up to:^a ^b Proctor 2000, p. 245
^ Proctor, Robert N. (1996). “Nazi Medicine and Public Health Policy”. Dimensions. 10 (2). Anti-Defamation League. Archived from the original on 5 December 2012. Retrieved 1 October 2018 – via archived copy at archive.is.
^ Doll, R.; Hill, A. B. (1 September 1950). “Smoking and Carcinoma of the Lung”. British Medical Journal. 2 (4682): 739–748. doi:10.1136/bmj.2.4682.739. ISSN 0007-1447. PMC 2038856. PMID 14772469.
^ “CNN Interactive”. Cnn.com. Archived from the original on 23 April 2009. Retrieved 22 June 2009.
^ “The Reports of the Surgeon General: The 1964 Report on Smoking and Health”. Profiles in Science. United States National Library of Medicine, National Institutes of Health. Archived from the original on 20 January 2016. Retrieved 10 October 2015.
^ Milo Geyelin (23 November 1998). “Forty-Six States Agree to Accept $206 Billion Tobacco Settlement”. Wall Street Journal.
^ Hilton, Matthew (4 May 2000). Smoking in British Popular Culture, 1800–2000: Perfect Pleasures. Manchester University Press. pp. 229–241. ISBN 978-0-7190-5257-6. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
^ Gilman & Xun 2004, pp. 46–57
^ Jump up to:^a ^b MPOWER 2008, pp. 267–288
^ “Bidi Use Among Urban Youth – Massachusetts, March–April 1999”. Centers for Disease Control and Prevention. 17 September 1999. Archived from the original on 11 February 2009. Retrieved 14 February 2009.
^ Pakhale, S. M.; Maru, G. B. (December 1998). “Distribution of major and minor alkaloids in tobacco, mainstream and sidestream smoke of popular Indian smoking products”. Food and Chemical Toxicology. 36 (12): 1131–1138. doi:10.1016/S0278-6915(98)00071-4. ISSN 0278-6915. PMID 9862656.
^ Rarick CA (2 April 2008). “Note on the premium cigar industry”. doi:10.2139/ssrn.1127582. S2CID 152340055. SSRN 1127582. {{cite journal}}: Cite journal requires |journal= (help)
^ Mariolis P, Rock VJ, Asman K, et al. (2006). “Tobacco use among adults—United States, 2005”. MMWR Morb Mortal Wkly Rep. 55 (42): 1145–8. PMID 17065979. Archived from the original on 26 September 2017. Retrieved 17 September 2017.
^ “A bill to protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products. (Summary)” (Press release). Library of Congress. 20 May 2004. Archived from the original on 4 September 2015. Retrieved 1 August 2007.
^ Turner, JA; Sillett, RW; McNicol, MW (1977). “Effect of cigar smoking on carboxyhemoglobin and plasma nicotine concentrations in primary pipe and cigar smokers and ex-cigarette smokers”. British Medical Journal. 2 (6099): 1387–9. doi:10.1136/bmj.2.6099.1387. PMC 1632361. PMID 589225.
^ Armitage, A. K.; Turner, D. M. (1970). “Absorption of Nicotine in Cigarette and Cigar Smoke through the Oral Mucosa”. Nature. 226 (5252): 1231–1232. Bibcode:1970Natur.226.1231A. doi:10.1038/2261231a0. PMID 5422597. S2CID 4208650.
^ Pich, E. M.; Pagliusi, S. R.; Tessari, M.; Talabot-Ayer, D.; Hooft Van Huijsduijnen, R.; Chiamulera, C. (1997). “Common neural substrates for the addictive properties of nicotine and cocaine”. Science. 275 (5296): 83–86. doi:10.1126/science.275.5296.83. PMID 8974398. S2CID 5923174.
^ Wonnacott, S. (1997). “Presynaptic nicotinic ACh receptors”. Trends in Neurosciences. 20 (2): 92–8. doi:10.1016/S0166-2236(96)10073-4. PMID 9023878. S2CID 42215860.
^ Pontieri, F. E.; Tanda, G.; Orzi, F.; Di Chiara, G. D. (1996). “Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs”. Nature. 382 (6588): 255–257. Bibcode:1996Natur.382..255P. doi:10.1038/382255a0. PMID 8717040. S2CID 4338516.
^ Guinan, M. E.; Portas, M. R.; Hill, H. R. (1979). “The candida precipitin test in an immunosuppressed population”. Cancer. 43 (1): 299–302. doi:10.1002/1097-0142(197901)43:1<299::AID-CNCR2820430143>3.0.CO;2-D. PMID 761168. S2CID 45096870.
^ Talhout, R.; Opperhuizen, A.; Van Amsterdam, J. G. C. (October 2007). “Role of acetaldehyde in tobacco smoke addiction”. European Neuropsychopharmacology. 17 (10): 627–636. doi:10.1016/j.euroneuro.2007.02.013. ISSN 0924-977X. PMID 17382522. S2CID 25866206.
^ Shoaib, M.; Lowe, A.; Williams, S. (2004). “Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats”. NeuroImage. 22 (2): 847–854. doi:10.1016/j.neuroimage.2004.01.026. PMID 15193614. S2CID 43544025.
^ Jump up to:^a ^b Guindon, G. Emmanuel; Boisclair, David (2003). “Past, current and future trends in tobacco use” (PDF). Washington DC: The International Bank for Reconstruction and Development / The World Bank: 13–16. Archived from the original (PDF) on 18 March 2009. Retrieved 22 March 2009. {{cite journal}}: Cite journal requires |journal= (help)
^ Peto, Richard; Lopez, Alan D; Boreham, Jillian; Thun, Michael (2006). “Mortality from Smoking in Developed Countries 1950–2000: indirect estimates from national vital statistics” (PDF). Oxford University Press: 9. Archived from the original (PDF) on 24 February 2005. Retrieved 22 March 2009. {{cite journal}}: Cite journal requires |journal= (help)
^ Tobaccofreekids.org/problem/tol-s
^ Centers for Disease Control and Prevention (CDC) (2009). “Cigarette smoking among adults and trends in smoking cessation – United States, 2008” (Full free text). MMWR. Morbidity and Mortality Weekly Report. 58 (44): 1227–1232. PMID 19910909. Archived from the original on 16 September 2017. Retrieved 17 September 2017.
^ GBD 2008, p. 8
^ GBD 2008, p. 23
^ Jump up to:^a ^b “WHO/WPRO-Tobacco Fact sheet”. World Health Organization Regional Office for the Western Pacific. 29 May 2007. Archived from the original on 7 February 2009. Retrieved 1 January 2009.
^ “Smoking causes one in 10 deaths worldwide, study shows”. BBC News. 6 April 2017. Archived from the original on 10 April 2017. Retrieved 11 April 2017.
^ Gay, Peter (1988). Freud: A Life for Our Time. New York: W. W. Norton & Company. pp. 650–651. ISBN 978-0-393-32861-5.
^ Patton G. C.; Hibbert M.; Rosier M. J.; Carlin J. B.; Caust J.; Bowes G. (1996). “Is smoking associated with depression and anxiety in teenagers?”. American Journal of Public Health. 86 (2): 225–230. doi:10.2105/ajph.86.2.225. PMC 1380332. PMID 8633740.
^ Stanton, W.; Silva, P. A. (1992). “A longitudinal study of the influence of parents and friends on children’s initiation of smoking”. Journal of Applied Developmental Psychology. 13 (4): 423–434. doi:10.1016/0193-3973(92)90010-F.
^ Harris, Judith Rich; Pinker, Steven (4 September 1998). The nurture assumption: why children turn out the way they do. Simon and Schuster. ISBN 978-0-684-84409-1. Archived from the original on 14 January 2023. Retrieved 22 March 2009.
^ Chassin, L.; Presson, C.; Rose, J.; Sherman, S. J.; Prost, J. (2002). “Parental Smoking Cessation and Adolescent Smoking”. Journal of Pediatric Psychology. 27 (6): 485–496. doi:10.1093/jpepsy/27.6.485. PMID 12177249.
^ Proescholdbell, R. J.; Chassin, L.; MacKinnon, D. P. (2000). “Home smoking restrictions and adolescent smoking”. Nicotine & Tobacco Research. 2 (2): 159–167. doi:10.1080/713688125. PMID 11072454. S2CID 8749779.
^ Urberg, K.; Shyu, S. J.; Liang, J. (1990). “Peer influence in adolescent cigarette smoking”. Addictive Behaviors. 15 (3): 247–255. doi:10.1016/0306-4603(90)90067-8. PMID 2378284.
^ Bharatula, Arun (2016). Review: Tobacco outlet density. Melbourne.^{[permanent dead link]}
^ Michell L, West P (1996). “Peer pressure to smoke: the meaning depends on the method”. Health Education Research. 11 (1): 39–49. doi:10.1093/her/11.1.39.
^ Barber, J.; Bolitho, F.; Bertrand, L. (1999). “The Predictors of Adolescent Smoking”. Journal of Social Service Research. 26 (1): 51–66. doi:10.1300/J079v26n01_03.
^ Pelosi, Anthony J. (2019). “Personality and fatal diseases: Revisiting a scientific scandal”. Journal of Health Psychology. 24 (4): 421–439. doi:10.1177/1359105318822045. ISSN 1359-1053. PMC 6712909. PMID 30791726.
^ “King’s College London enquiry into publications authored by Professor Hans Eysenck with Professor Ronald Grossarth-Maticek” (PDF). October 2019. Archived (PDF) from the original on 5 November 2022. Retrieved 13 January 2020.
^ Nigel Hawkes (2019), Works by eminent psychologist who doubted smoking caused cancer are “unsafe,” finds inquiry Archived 4 January 2023 at the Wayback Machine
^ Eysenck, Hans J.; Brody, Stuart (November 2000). Smoking, health and personality. Transaction. ISBN 978-0-7658-0639-0.
^ Berlin, I.; Singleton, E. G.; Pedarriosse, A. M.; Lancrenon, S.; Rames, A.; Aubin, H. J.; Niaura, R. (2003). “The Modified Reasons for Smoking Scale: factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers”. Addiction. 98 (11): 1575–1583. doi:10.1046/j.1360-0443.2003.00523.x. PMID 14616184.
^ “Nicotine”. Imperial College London. Archived from the original on 14 July 2009. Retrieved 22 March 2009. {{cite journal}}: Cite journal requires |journal= (help)
^ Chandra, S.; Chaloupka, F. J. (2003). “Seasonality in cigarette sales: patterns and implications for tobacco control”. Tobacco Control. 12 (1): 105–107. doi:10.1136/tc.12.1.105. PMC 1759100. PMID 12612375.
^ Chandra, S.; Shiffman, S.; Scharf, M.; Dang, Q.; Shadel, G. (February 2007). “Daily smoking patterns, their determinants, and implications for quitting”. Experimental and Clinical Psychopharmacology. 15 (1): 67–80. doi:10.1037/1064-1297.15.1.67. ISSN 1064-1297. PMID 17295586.
^ Jump up to:^a ^b Kalkhoran, S; Benowitz, NL; Rigotti, AN (August 2018). “Prevention and Treatment of Tobacco Use: JACC Health Promotion Series”. Journal of the American College of Cardiology. 72 (9). Elsevier for the American College of Cardiology: 1030–45. doi:10.1016/j.jacc.2018.06.036. ISSN 1558-3597. PMC 6261256. PMID 30139432. S2CID 52077567. Archived from the original on 9 August 2020. Retrieved 1 August 2020.
^ “ASH > Action on Smoking & Health”. www.ash.org. 2 August 2012. Archived from the original on 19 November 2016. Retrieved 16 November 2016.
^ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Mitchell, Richard (18 May 2007). “Chapter 8: Environmental and Nutritional Diseases”. Robbins Basic Pathology (8th ed.). Philadelphia: W.B. Saunders. p. 288, Figure 8–6. ISBN 978-1-4160-2973-1.
^ Jump up to:^a ^b ^c Rodu, B; Plurphanswat, N (January 2021). “Mortality among male cigar and cigarette smokers in the USA” (PDF). Harm Reduction Journal. 18 (7). BioMed Central: 7. doi:10.1186/s12954-020-00446-4. ISSN 1477-7517. LCCN 2004243422. PMC 7789747. PMID 33413424. S2CID 230800394. Archived (PDF) from the original on 26 August 2021. Retrieved 28 August 2021.
^ Nonnemaker, J; Rostron, B; Hall, P; MacMonegle, A; Apelberg, B (September 2014). Morabia, A (ed.). “Mortality and Economic Costs From Regular Cigar Use in the United States, 2010”. American Journal of Public Health. 104 (9). American Public Health Association: e86 – e91. doi:10.2105/AJPH.2014.301991. eISSN 1541-0048. ISSN 0090-0036. PMC 4151956. PMID 25033140. S2CID 207276270.
^ Shah, RS; Cole, JW (July 2010). “Smoking and stroke: the more you smoke the more you stroke”. Expert Review of Cardiovascular Therapy. 8 (7). Informa: 917–932. doi:10.1586/erc.10.56. ISSN 1744-8344. PMC 2928253. PMID 20602553. S2CID 207215548.
^ Jump up to:^a ^b Laniado-Laborín, Rafael (January 2009). “Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century”. International Journal of Environmental Research and Public Health. 6 (1: Smoking and Tobacco Control). MDPI: 209–224. doi:10.3390/ijerph6010209. ISSN 1660-4601. PMC 2672326. PMID 19440278. S2CID 19615031.
^ Oh, CK; Murray, LA; Molfino, NL (February 2012). “Smoking and Idiopathic Pulmonary Fibrosis”. Pulmonary Medicine. 2012. Hindawi Publishing Corporation: 808260. doi:10.1155/2012/808260. ISSN 2090-1844. PMC 3289849. PMID 22448328. S2CID 14090263.
^ Jump up to:^a ^b ^c Thun, Michael J.; Jacobs, Eric J.; Shapiro, Jean A. (February 2000). Ganz, Patricia A. (ed.). “Cigar Smoking in Men and Risk of Death From Tobacco-Related Cancers”. Journal of the National Cancer Institute. 92 (4). Oxford University Press: 333–337. doi:10.1093/jnci/92.4.333. eISSN 1460-2105. ISSN 0027-8874. PMID 10675383. S2CID 7772405. Archived from the original on 21 April 2021. Retrieved 28 August 2021.
^ Jump up to:^a ^b ^c Anjum F, Zohaib J (4 December 2020). “Oropharyngeal Squamous Cell Carcinoma”. Definitions (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
^ Gormley, Mark; Creaney, Grant; Schache, Andrew; Ingarfield, Kate; Conway, David I. (11 November 2022). “Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors”. British Dental Journal. 233 (9): 780–786. doi:10.1038/s41415-022-5166-x. ISSN 0007-0610. PMC 9652141. PMID 36369568.
^ Hashibe, Mia; Brennan, Paul; Chuang, Shu-chun; Boccia, Stefania; Castellsague, Xavier; Chen, Chu; Curado, Maria Paula; Dal Maso, Luigino; Daudt, Alexander W.; Fabianova, Eleonora; Fernandez, Leticia; Wünsch-Filho, Victor; Franceschi, Silvia; Hayes, Richard B.; Herrero, Rolando (1 February 2009). “Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium”. Cancer Epidemiology, Biomarkers & Prevention. 18 (2): 541–550. doi:10.1158/1055-9965.EPI-08-0347. ISSN 1055-9965. PMC 3051410. PMID 19190158.
^ Inflamm Bowel Dis. May 2009, P. Seksik, I Nion-Larmurier
^ Rom O, Kaisari S, Aizenbud D, Reznick AZ (2013). “Cigarette smoke and muscle catabolism in C2 myotubes”. Mech Ageing Dev. 134 (1–2): 24–34. doi:10.1016/j.mad.2012.11.004. PMID 23262287. S2CID 322153.
^ Jump up to:^a ^b Etemadi, Arash; Blount, Benjamin C.; Calafat, Antonia M.; Chang, Cindy M.; De Jesus, Victor R.; Poustchi, Hossein; Wang, Lanqing; Pourshams, Akram; Shakeri, Ramin; Shiels, Meredith S.; Inoue-Choi, Maki; Ambrose, Bridget K.; Christensen, Carol H.; Wang, Baoguang; Ye, Xiaoyun; Murphy, Gwen; Feng, Jun; Xia, Baoyun; Sosnoff, Connie S.; Boffetta, Paolo; Brennan, Paul; Bhandari, Deepak; Kamangar, Farin; Dawsey, Sanford M.; Abnet, Christian C.; Freedman, Neal D.; Malekzadeh, Reza (February 2019). “Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study”. Cancer Epidemiology, Biomarkers & Prevention. 28 (2). American Association for Cancer Research: 337–347. doi:10.1158/1055-9965.EPI-18-0743. eISSN 1538-7755. ISSN 1055-9965. PMC 6935158. PMID 30622099. S2CID 58560832.
^ Dreyer, L et al. (1997) Tobacco Smoking. APMIS Inc.
^ Chang, Cindy M.; Corey, Catherine G.; Rostron, Brian L.; Apelberg, Benjamin J. (April 2015). “Systematic review of cigar smoking and all-cause and smoking-related mortality” (PDF). BMC Public Health. 15 (390). BioMed Central: 390. doi:10.1186/s12889-015-1617-5. ISSN 1471-2458. PMC 4408600. PMID 25907101. S2CID 16482278. Archived (PDF) from the original on 16 March 2021. Retrieved 5 September 2021.
^ Albandar, Jasim M.; Adensaya, Margo R.; Streckfus, Charles F.; Winn, Deborah M. (December 2000). “Cigar, Pipe, and Cigarette Smoking as Risk Factors for Periodontal Disease and Tooth Loss”. Journal of Periodontology. 71 (12). American Academy of Periodontology: 1874–1881. doi:10.1902/jop.2000.71.12.1874. ISSN 0022-3492. PMID 11156044. S2CID 11598500.
^ Kastan MB (2008). “DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture”. Mol. Cancer Res. 6 (4): 517–24. doi:10.1158/1541-7786.MCR-08-0020. PMID 18403632.
^ Liu XY, Zhu MX, Xie JP (2010). “Mutagenicity of acrolein and acrolein-induced DNA adducts”. Toxicol. Mech. Methods. 20 (1): 36–44. doi:10.3109/15376510903530845. PMID 20158384. S2CID 8812192.
^ Speit G, Merk O (2002). “Evaluation of mutagenic effects of formaldehyde in vitro: detection of crosslinks and mutations in mouse lymphoma cells”. Mutagenesis. 17 (3): 183–7. doi:10.1093/mutage/17.3.183. PMID 11971987.
^ Pu X, Kamendulis LM, Klaunig JE (2009). “Acrylonitrile-induced oxidative stress and oxidative DNA damage in male Sprague-Dawley rats”. Toxicol. Sci. 111 (1): 64–71. doi:10.1093/toxsci/kfp133. PMC 2726299. PMID 19546159.
^ Koturbash I, Scherhag A, Sorrentino J, Sexton K, Bodnar W, Swenberg JA, Beland FA, Pardo-Manuel Devillena F, Rusyn I, Pogribny IP (2011). “Epigenetic mechanisms of mouse interstrain variability in genotoxicity of the environmental toxicant 1,3-butadiene”. Toxicol. Sci. 122 (2): 448–56. doi:10.1093/toxsci/kfr133. PMC 3155089. PMID 21602187.
^ Garcia CC, Angeli JP, Freitas FP, Gomes OF, de Oliveira TF, Loureiro AP, Di Mascio P, Medeiros MH (2011). “[13C2]-Acetaldehyde promotes unequivocal formation of 1,N2-propano-2′-deoxyguanosine in human cells”. J. Am. Chem. Soc. 133 (24): 9140–3. doi:10.1021/ja2004686. PMID 21604744. Archived from the original on 6 November 2020. Retrieved 1 December 2019.
^ Tompkins EM, McLuckie KI, Jones DJ, Farmer PB, Brown K (2009). “Mutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cells”. Mutat. Res. 678 (2): 129–37. Bibcode:2009MRGTE.678..129T. doi:10.1016/j.mrgentox.2009.05.011. PMID 19477295.
^ Fabiani R, Rosignoli P, De Bartolomeo A, Fuccelli R, Morozzi G (2007). “DNA-damaging ability of isoprene and isoprene mono-epoxide (EPOX I) in human cells evaluated with the comet assay”. Mutat. Res. 629 (1): 7–13. Bibcode:2007MRGTE.629….7F. doi:10.1016/j.mrgentox.2006.12.007. PMID 17317274.
^ Alarabi, A. B.; Karim, Z. A.; Alshbool, F. Z.; Khasawneh, F. T.; Hernandez, Keziah R.; Lozano, Patricia A.; Montes Ramirez, Jean E.; Rivera, José O. (February 2020). “Short-Term Exposure to Waterpipe/Hookah Smoke Triggers a Hyperactive Platelet Activation State and Increases the Risk of Thrombogenesis”. Arteriosclerosis, Thrombosis, and Vascular Biology. 40 (2). Lippincott Williams & Wilkins: 335–349. doi:10.1161/ATVBAHA.119.313435. ISSN 1079-5642. PMC 7000176. PMID 31941383. S2CID 210335103.
^ Patel, Mit P.; Khangoora, Vikramjit S.; Marik, Paul E. (October 2019). “A Review of the Pulmonary and Health Impacts of Hookah Use”. Annals of the American Thoracic Society. 16 (10). American Thoracic Society: 1215–1219. doi:10.1513/AnnalsATS.201902-129CME. ISSN 2325-6621. PMID 31091965. S2CID 155103502.
^ Qasim, Hanan; Alarabi, A. B.; Alzoubi, K. H.; Karim, Z. A.; Alshbool, F. Z.; Khasawneh, F. T. (September 2019). “The effects of hookah/waterpipe smoking on general health and the cardiovascular system” (PDF). Environmental Health and Preventive Medicine. 24 (58). BioMed Central: 58. Bibcode:2019EHPM…24…58Q. doi:10.1186/s12199-019-0811-y. ISSN 1347-4715. PMC 6745078. PMID 31521105. S2CID 202570973. Archived (PDF) from the original on 24 April 2021. Retrieved 8 September 2021.
^ Jump up to:^a ^b Farag, Mohamed A.; Elmassry, Moamen M.; El-Ahmady, Sherweit H. (19 November 2018). “The characterization of flavored hookahs aroma profile and in response to heating as analyzed via headspace solid-phase microextraction (SPME) and chemometrics”. Scientific Reports. 8 (1): 17028. Bibcode:2018NatSR…817028F. doi:10.1038/s41598-018-35368-6. ISSN 2045-2322. PMC 6242864. PMID 30451904.
^ WHO Report on the Global Tobacco Epidemic, 2008
^ “Nicotine: A Powerful Addiction Archived 1 May 2009 at the Wayback Machine.” Centers for Disease Control and Prevention.
^ Jump up to:^a ^b Barendregt J. J., Bonneux L., van der Maas P. J. (1997). “The health care costs of smoking” (PDF). New England Journal of Medicine. 337 (15): 1052–1057. doi:10.1056/NEJM199710093371506. hdl:1765/59780. PMID 9321534. Archived (PDF) from the original on 8 October 2022. Retrieved 20 April 2018.
^ Peto Richard; Darby Sarah; Deo Harz; et al. (2000). “Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies”. The BMJ. 321 (7257): 323–329. doi:10.1136/bmj.321.7257.323. PMC 27446. PMID 10926586.
^ Yoshida, Kenichi; Gowers, Kate H. C.; Lee-Six, Henry; Chandrasekharan, Deepak P.; Coorens, Tim; Maughan, Elizabeth F.; Beal, Kathryn; Menzies, Andrew; Millar, Fraser R.; Anderson, Elizabeth; Clarke, Sarah E.; Pennycuick, Adam; Thakrar, Ricky M.; Butler, Colin R.; Kakiuchi, Nobuyuki; Hirano, Tomonori; Hynds, Robert E.; Stratton, Michael R.; Martincorena, Iñigo; Janes, Sam M.; Campbell, Peter J. (2020). “Tobacco smoking and somatic mutations in human bronchial epithelium”. Nature. 578 (7794): 266–272. Bibcode:2020Natur.578..266Y. doi:10.1038/s41586-020-1961-1. PMC 7021511. PMID 31996850. Archived from the original on 12 August 2021. Retrieved 30 January 2020.